Amytrophic lateral sclerosis Amitropic lateral sclerosis, also known as Charcot's disease, is a rare neurological disorder that destroys the motor neurons that control muscles. Symptoms include weakness and progressive wasting of muscles, especially the limbs. This disease slowly kills muscle fibers and becomes apparent when the lesion is almost complete. Although several treatments are available, in most cases death can be caused by a variety of factors, such as hypothyroidism, cardiac decompensation and pulmonary disease. Find out more about this disease here.
The article is called: "Amytrophic lateral skelesis"
Introduction Amytrophic lateral sclerosis – synonym. Shalko's disease is a disease of the nervous system leading to paralysis of skeletal muscles. It is caused by dysfunction of bone marrow stem cells and the progressive replacement of normally functioning neurons by hypertrophic neuroglial cells. The effects of the disease range from mild weakness to complete immobility and loss of bowel and bladder control.
There are several different approaches to treating SBAL in mild to moderate forms of the disease, including symptomatic treatment, drug therapy, surgery, and exercise therapy.
Pathogenesis The causes of SBAL are unknown, but it is a progressive disease that usually affects people over the age of 60 years. Usually caused by genetic factors or associated with certain infectious diseases. There is a misconception that the disease can be cured using mitochondrial proteins. - The first signs of SBEAL are headaches, irritability, memory loss, changes in sense of smell and taste. If the disease is not treated from the very beginning, it progresses slowly. This is characterized by weakness, fever, pain in the back and face, brittle bones, and paralysis. After visiting a doctor, the person will be prescribed neuroprotective treatment. Neurontivating therapeutic drugs are used to improve the patient’s brain functions, as well as symptomatic drugs. As a result of successful therapy for SBAL, the patient significantly improves the quality of his life, the risk of complications decreases and the prognosis for the patient improves.